December 31, 2007
Rigel hopes its arthritis drug will be a star (BizJournals)
Rigel Pharmaceuticals Inc. hopes to capitalize on strong clinical data to lead a pack of second-generation rheumatoid arthritis drugs.
Read full story
Rigel Pharmaceuticals Inc. hopes to capitalize on strong clinical data to lead a pack of second-generation rheumatoid arthritis drugs.
Read full story
MorphoSys has submitted a clinical trial application to initiate a Phase I trial using the HuCAL-derived antibody MOR103 for the treatment of rheumatoid arthritis.
Read full story
Erica Schmude of Mechanicsville gained national attention recently when her artwork was selected as the design for the 2007 National Arthritis Foundation holiday card.
Read full story
Physicians typically see a sharp increase in big toe injuries in the winter, a U.S. foot and ankle specialist reports.
Read full story